Vascepa Infringement Dismissal ‘Resulted In Multiple Errors,’ Amarin Argues
Originator Launches Opening Salvo In Bid To Have Dismissal Overturned
Amarin is digging deep to take Hikma back before a US district court in its induced infringement case against the generics manufacturer.
